APO Research
Talk to an analyst

APO RESEARCH · REPORT

GABA Receptor Modulators

Compare research editions
View pricing & licenses

Selected research

Industry Research

GABA Receptor Modulators Industry Research Report 2026

20 December 2025148 pages

Choose your research edition.

Industry ResearchGABA Receptor Modulators Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal GABA Receptor Modulators Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal GABA Receptor Modulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABA Receptor Modulators Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal GABA Receptor Modulators Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global GABA Receptor Modulators market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for GABA Receptor Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for GABA Receptor Modulators is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for GABA Receptor Modulators is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of GABA Receptor Modulators include Takeda, Teva, Sun Pharma, Shanghai Pharmaceuticals Holding, Sanofi, Novartis, Mylan, Roche and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global GABA Receptor Modulators market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

GABA Receptor Modulators Market by Company

Takeda

Teva

Sun Pharma

Shanghai Pharmaceuticals Holding

Sanofi

Novartis

Mylan

Roche

Pfizer

Huazhong Pharmaceutical

Sichuan HaiscoPharmaceuical

GSK

Fresenius Kabi

Changzhou Siyao Pharmaceutical

AstraZeneca

WG Critical Care

Viatris

Torrent Pharma

Sandoz

SAGE Therapeutics

Neurelis

Jazz Pharmaceuicals

Hikma

CHEPLAPHARM

Apotex

Akorn

GABA Receptor Modulators Segment by Type

GABAA Receptors

GABAB Receptors

GABAC Receptors

GABA Receptor Modulators Segment by Application

Epilepsy

Anxiety

Neuropathic Pain

Insomnia

Other

GABA Receptor Modulators Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABA Receptor Modulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABA Receptor Modulators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABA Receptor Modulators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of GABA Receptor Modulators manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of GABA Receptor Modulators by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of GABA Receptor Modulators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global GABA Receptor Modulators Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global GABA Receptor Modulators Sales (K Units) of Manufacturers (2021-2026) Table 7. Global GABA Receptor Modulators Sales Market Share by Manufacturers (2021-2026) Table 8. Global GABA Receptor Modulators Revenue of Manufacturers (2021-2026) Table 9. Global GABA Receptor Modulators Revenue Share by Manufacturers (2021-2026) Table 10. Global Market GABA Receptor Modulators Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global GABA Receptor Modulators Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of GABA Receptor Modulators, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of GABA Receptor Modulators, Product Type & Application Table 14. Global GABA Receptor Modulators Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global GABA Receptor Modulators by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Takeda Company Information Table 19. Takeda Business Overview Table 20. Takeda GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Takeda GABA Receptor Modulators Product Portfolio Table 22. Takeda Recent Developments Table 23. Teva Company Information Table 24. Teva Business Overview Table 25. Teva GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Teva GABA Receptor Modulators Product Portfolio Table 27. Teva Recent Developments Table 28. Sun Pharma Company Information Table 29. Sun Pharma Business Overview Table 30. Sun Pharma GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Sun Pharma GABA Receptor Modulators Product Portfolio Table 32. Sun Pharma Recent Developments Table 33. Shanghai Pharmaceuticals Holding Company Information Table 34. Shanghai Pharmaceuticals Holding Business Overview Table 35. Shanghai Pharmaceuticals Holding GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Shanghai Pharmaceuticals Holding GABA Receptor Modulators Product Portfolio Table 37. Shanghai Pharmaceuticals Holding Recent Developments Table 38. Sanofi Company Information Table 39. Sanofi Business Overview Table 40. Sanofi GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Sanofi GABA Receptor Modulators Product Portfolio Table 42. Sanofi Recent Developments Table 43. Novartis Company Information Table 44. Novartis Business Overview Table 45. Novartis GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Novartis GABA Receptor Modulators Product Portfolio Table 47. Novartis Recent Developments Table 48. Mylan Company Information Table 49. Mylan Business Overview Table 50. Mylan GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Mylan GABA Receptor Modulators Product Portfolio Table 52. Mylan Recent Developments Table 53. Roche Company Information Table 54. Roche Business Overview Table 55. Roche GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Roche GABA Receptor Modulators Product Portfolio Table 57. Roche Recent Developments Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Pfizer GABA Receptor Modulators Product Portfolio Table 62. Pfizer Recent Developments Table 63. Huazhong Pharmaceutical Company Information Table 64. Huazhong Pharmaceutical Business Overview Table 65. Huazhong Pharmaceutical GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Huazhong Pharmaceutical GABA Receptor Modulators Product Portfolio Table 67. Huazhong Pharmaceutical Recent Developments Table 68. Sichuan HaiscoPharmaceuical Company Information Table 69. Sichuan HaiscoPharmaceuical Business Overview Table 70. Sichuan HaiscoPharmaceuical GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sichuan HaiscoPharmaceuical GABA Receptor Modulators Product Portfolio Table 72. Sichuan HaiscoPharmaceuical Recent Developments Table 73. GSK Company Information Table 74. GSK Business Overview Table 75. GSK GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. GSK GABA Receptor Modulators Product Portfolio Table 77. GSK Recent Developments Table 78. Fresenius Kabi Company Information Table 79. Fresenius Kabi Business Overview Table 80. Fresenius Kabi GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Fresenius Kabi GABA Receptor Modulators Product Portfolio Table 82. Fresenius Kabi Recent Developments Table 83. Changzhou Siyao Pharmaceutical Company Information Table 84. Changzhou Siyao Pharmaceutical Business Overview Table 85. Changzhou Siyao Pharmaceutical GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Changzhou Siyao Pharmaceutical GABA Receptor Modulators Product Portfolio Table 87. Changzhou Siyao Pharmaceutical Recent Developments Table 88. AstraZeneca Company Information Table 89. AstraZeneca Business Overview Table 90. AstraZeneca GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. AstraZeneca GABA Receptor Modulators Product Portfolio Table 92. AstraZeneca Recent Developments Table 93. WG Critical Care Company Information Table 94. WG Critical Care Business Overview Table 95. WG Critical Care GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. WG Critical Care GABA Receptor Modulators Product Portfolio Table 97. WG Critical Care Recent Developments Table 98. Viatris Company Information Table 99. Viatris Business Overview Table 100. Viatris GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Viatris GABA Receptor Modulators Product Portfolio Table 102. Viatris Recent Developments Table 103. Torrent Pharma Company Information Table 104. Torrent Pharma Business Overview Table 105. Torrent Pharma GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Torrent Pharma GABA Receptor Modulators Product Portfolio Table 107. Torrent Pharma Recent Developments Table 108. Sandoz Company Information Table 109. Sandoz Business Overview Table 110. Sandoz GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Sandoz GABA Receptor Modulators Product Portfolio Table 112. Sandoz Recent Developments Table 113. SAGE Therapeutics Company Information Table 114. SAGE Therapeutics Business Overview Table 115. SAGE Therapeutics GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. SAGE Therapeutics GABA Receptor Modulators Product Portfolio Table 117. SAGE Therapeutics Recent Developments Table 118. Neurelis Company Information Table 119. Neurelis Business Overview Table 120. Neurelis GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Neurelis GABA Receptor Modulators Product Portfolio Table 122. Neurelis Recent Developments Table 123. Jazz Pharmaceuicals Company Information Table 124. Jazz Pharmaceuicals Business Overview Table 125. Jazz Pharmaceuicals GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Jazz Pharmaceuicals GABA Receptor Modulators Product Portfolio Table 127. Jazz Pharmaceuicals Recent Developments Table 128. Hikma Company Information Table 129. Hikma Business Overview Table 130. Hikma GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Hikma GABA Receptor Modulators Product Portfolio Table 132. Hikma Recent Developments Table 133. CHEPLAPHARM Company Information Table 134. CHEPLAPHARM Business Overview Table 135. CHEPLAPHARM GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. CHEPLAPHARM GABA Receptor Modulators Product Portfolio Table 137. CHEPLAPHARM Recent Developments Table 138. Apotex Company Information Table 139. Apotex Business Overview Table 140. Apotex GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Apotex GABA Receptor Modulators Product Portfolio Table 142. Apotex Recent Developments Table 143. Akorn Company Information Table 144. Akorn Business Overview Table 145. Akorn GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Akorn GABA Receptor Modulators Product Portfolio Table 147. Akorn Recent Developments Table 148. Global GABA Receptor Modulators Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 149. Global GABA Receptor Modulators Sales by Region (2021-2026) & (K Units) Table 150. Global GABA Receptor Modulators Sales Market Share by Region (2021-2026) Table 151. Global GABA Receptor Modulators Sales by Region (2027-2032) & (K Units) Table 152. Global GABA Receptor Modulators Sales Market Share by Region (2027-2032) Table 153. Global GABA Receptor Modulators Revenue by Region (2021-2026) & (US$ Million) Table 154. Global GABA Receptor Modulators Revenue Market Share by Region (2021-2026) Table 155. Global GABA Receptor Modulators Revenue by Region (2027-2032) & (US$ Million) Table 156. Global GABA Receptor Modulators Revenue Market Share by Region (2027-2032) Table 157. North America GABA Receptor Modulators Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. North America GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 159. North America GABA Receptor Modulators Sales by Country (2027-2032) & (K Units) Table 160. North America GABA Receptor Modulators Revenue by Country (2021-2026) & (US$ Million) Table 161. North America GABA Receptor Modulators Revenue by Country (2027-2032) & (US$ Million) Table 162. Europe GABA Receptor Modulators Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Europe GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 164. Europe GABA Receptor Modulators Sales by Country (2027-2032) & (K Units) Table 165. Europe GABA Receptor Modulators Revenue by Country (2021-2026) & (US$ Million) Table 166. Europe GABA Receptor Modulators Revenue by Country (2027-2032) & (US$ Million) Table 167. Asia Pacific GABA Receptor Modulators Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. Asia Pacific GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 169. Asia Pacific GABA Receptor Modulators Sales by Country (2027-2032) & (K Units) Table 170. Asia Pacific GABA Receptor Modulators Revenue by Country (2021-2026) & (US$ Million) Table 171. Asia Pacific GABA Receptor Modulators Revenue by Country (2027-2032) & (US$ Million) Table 172. South America GABA Receptor Modulators Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 173. South America GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 174. South America GABA Receptor Modulators Sales by Country (2027-2032) & (K Units) Table 175. South America GABA Receptor Modulators Revenue by Country (2021-2026) & (US$ Million) Table 176. South America GABA Receptor Modulators Revenue by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa GABA Receptor Modulators Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 178. Middle East and Africa GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 179. Middle East and Africa GABA Receptor Modulators Sales by Country (2027-2032) & (K Units) Table 180. Middle East and Africa GABA Receptor Modulators Revenue by Country (2021-2026) & (US$ Million) Table 181. Middle East and Africa GABA Receptor Modulators Revenue by Country (2027-2032) & (US$ Million) Table 182. Global GABA Receptor Modulators Sales by Type (2021-2026) & (K Units) Table 183. Global GABA Receptor Modulators Sales by Type (2027-2032) & (K Units) Table 184. Global GABA Receptor Modulators Sales Market Share by Type (2021-2026) Table 185. Global GABA Receptor Modulators Sales Market Share by Type (2027-2032) Table 186. Global GABA Receptor Modulators Revenue by Type (2021-2026) & (US$ Million) Table 187. Global GABA Receptor Modulators Revenue by Type (2027-2032) & (US$ Million) Table 188. Global GABA Receptor Modulators Revenue Market Share by Type (2021-2026) Table 189. Global GABA Receptor Modulators Revenue Market Share by Type (2027-2032) Table 190. Global GABA Receptor Modulators Price by Type (2021-2026) & (US$/Unit) Table 191. Global GABA Receptor Modulators Price by Type (2027-2032) & (US$/Unit) Table 192. Global GABA Receptor Modulators Sales by Application (2021-2026) & (K Units) Table 193. Global GABA Receptor Modulators Sales by Application (2027-2032) & (K Units) Table 194. Global GABA Receptor Modulators Sales Market Share by Application (2021-2026) Table 195. Global GABA Receptor Modulators Sales Market Share by Application (2027-2032) Table 196. Global GABA Receptor Modulators Revenue by Application (2021-2026) & (US$ Million) Table 197. Global GABA Receptor Modulators Revenue by Application (2027-2032) & (US$ Million) Table 198. Global GABA Receptor Modulators Revenue Market Share by Application (2021-2026) Table 199. Global GABA Receptor Modulators Revenue Market Share by Application (2027-2032) Table 200. Global GABA Receptor Modulators Price by Application (2021-2026) & (US$/Unit) Table 201. Global GABA Receptor Modulators Price by Application (2027-2032) & (US$/Unit) Table 202. Key Raw Materials Table 203. Raw Materials Key Suppliers Table 204. GABA Receptor Modulators Distributors List Table 205. GABA Receptor Modulators Customers List Table 206. GABA Receptor Modulators Industry Trends Table 207. GABA Receptor Modulators Industry Drivers Table 208. GABA Receptor Modulators Industry Restraints Table 209. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. GABA Receptor Modulators Product Image Figure 5. Global GABA Receptor Modulators Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global GABA Receptor Modulators Market Size (2021-2032) & (US$ Million) Figure 7. Global GABA Receptor Modulators Sales (2021-2032) & (K Units) Figure 8. Global GABA Receptor Modulators Average Price (US$/Unit) & (2021-2032) Figure 9. GABAA Receptors Product Image Figure 10. GABAB Receptors Product Image Figure 11. GABAC Receptors Product Image Figure 12. Epilepsy Product Image Figure 13. Anxiety Product Image Figure 14. Neuropathic Pain Product Image Figure 15. Insomnia Product Image Figure 16. Other Product Image Figure 17. Global GABA Receptor Modulators Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of GABA Receptor Modulators, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 GABA Receptor Modulators Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global GABA Receptor Modulators Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global GABA Receptor Modulators Sales by Region in 2025 Figure 23. Global GABA Receptor Modulators Revenue by Region in 2025 Figure 24. North America GABA Receptor Modulators Market Size by Country in 2025 Figure 25. North America GABA Receptor Modulators Sales Market Share by Country (2021-2032) Figure 26. North America GABA Receptor Modulators Revenue Market Share by Country (2021-2032) Figure 27. United States GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe GABA Receptor Modulators Market Size by Country in 2025 Figure 30. Europe GABA Receptor Modulators Sales Market Share by Country (2021-2032) Figure 31. Europe GABA Receptor Modulators Revenue Market Share by Country (2021-2032) Figure 32. Germany GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Asia Pacific GABA Receptor Modulators Market Size by Country in 2025 Figure 38. Asia Pacific GABA Receptor Modulators Sales Market Share by Country (2021-2032) Figure 39. Asia Pacific GABA Receptor Modulators Revenue Market Share by Country (2021-2032) Figure 40. China GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Japan GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. South Korea GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. India GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Australia GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. China Taiwan GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South America GABA Receptor Modulators Market Size by Country in 2025 Figure 49. South America GABA Receptor Modulators Sales Market Share by Country (2021-2032) Figure 50. South America GABA Receptor Modulators Revenue Market Share by Country (2021-2032) Figure 51. Mexico GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Brazil GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Argentina GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Middle East and Africa GABA Receptor Modulators Market Size by Country in 2025 Figure 55. Middle East and Africa GABA Receptor Modulators Sales Market Share by Country (2021-2032) Figure 56. Middle East and Africa GABA Receptor Modulators Revenue Market Share by Country (2021-2032) Figure 57. Turkey GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Saudi Arabia GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. UAE GABA Receptor Modulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Global GABA Receptor Modulators Sales Market Share by Type (2021-2032) Figure 61. Global GABA Receptor Modulators Revenue Market Share by Type (2021-2032) Figure 62. Global GABA Receptor Modulators Price (US$/Unit) by Type (2021-2032) Figure 63. Global GABA Receptor Modulators Sales Market Share by Application (2021-2032) Figure 64. Global GABA Receptor Modulators Revenue Market Share by Application (2021-2032) Figure 65. Global GABA Receptor Modulators Price (US$/Unit) by Application (2021-2032) Figure 66. GABA Receptor Modulators Value Chain Figure 67. GABA Receptor Modulators Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. GABA Receptor Modulators Industry Opportunities and Challenges

Scope & coverage.

Types
  • GABAA Receptors
  • GABAB Receptors
  • GABAC Receptors
Applications
  • Epilepsy
  • Anxiety
  • Neuropathic Pain
  • Insomnia
  • Other
Companies covered
  • Takeda
  • Teva
  • Sun Pharma
  • Shanghai Pharmaceuticals Holding
  • Sanofi
  • Novartis
  • Mylan
  • Roche
  • Pfizer
  • Huazhong Pharmaceutical
  • Sichuan HaiscoPharmaceuical
  • GSK
  • Fresenius Kabi
  • Changzhou Siyao Pharmaceutical
  • AstraZeneca
  • WG Critical Care
  • Viatris
  • Torrent Pharma
  • Sandoz
  • SAGE Therapeutics
  • Neurelis
  • Jazz Pharmaceuicals
  • Hikma
  • CHEPLAPHARM
  • Apotex
  • Akorn

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global GABA Receptor Modulators Market Size (2021-2032)
  4. 2.2.2 Global GABA Receptor Modulators Sales (2021-2032)
  5. 2.2.3 Global GABA Receptor Modulators Market Average Price (2021-2032)
  6. 2.3 GABA Receptor Modulators by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 GABAA Receptors
  9. 2.3.3 GABAB Receptors
  10. 2.3.4 GABAC Receptors
  11. 2.4 GABA Receptor Modulators by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Epilepsy
  14. 2.4.3 Anxiety
  15. 2.4.4 Neuropathic Pain
  16. 2.4.5 Insomnia
  17. 2.4.6 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global GABA Receptor Modulators Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global GABA Receptor Modulators Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global GABA Receptor Modulators Revenue of Manufacturers (2021-2026)
  4. 3.4 Global GABA Receptor Modulators Average Price by Manufacturers (2021-2026)
  5. 3.5 Global GABA Receptor Modulators Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of GABA Receptor Modulators, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of GABA Receptor Modulators, Product Type & Application
  8. 3.8 Global Manufacturers of GABA Receptor Modulators, Established Date
  9. 3.9 Global GABA Receptor Modulators Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Takeda
  2. 4.1.1 Takeda Company Information
  3. 4.1.2 Takeda Business Overview
  4. 4.1.3 Takeda GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Takeda GABA Receptor Modulators Product Portfolio
  6. 4.1.5 Takeda Recent Developments
  7. 4.2 Teva
  8. 4.2.1 Teva Company Information
  9. 4.2.2 Teva Business Overview
  10. 4.2.3 Teva GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Teva GABA Receptor Modulators Product Portfolio
  12. 4.2.5 Teva Recent Developments
  13. 4.3 Sun Pharma
  14. 4.3.1 Sun Pharma Company Information
  15. 4.3.2 Sun Pharma Business Overview
  16. 4.3.3 Sun Pharma GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Sun Pharma GABA Receptor Modulators Product Portfolio
  18. 4.3.5 Sun Pharma Recent Developments
  19. 4.4 Shanghai Pharmaceuticals Holding
  20. 4.4.1 Shanghai Pharmaceuticals Holding Company Information
  21. 4.4.2 Shanghai Pharmaceuticals Holding Business Overview
  22. 4.4.3 Shanghai Pharmaceuticals Holding GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Shanghai Pharmaceuticals Holding GABA Receptor Modulators Product Portfolio
  24. 4.4.5 Shanghai Pharmaceuticals Holding Recent Developments
  25. 4.5 Sanofi
  26. 4.5.1 Sanofi Company Information
  27. 4.5.2 Sanofi Business Overview
  28. 4.5.3 Sanofi GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Sanofi GABA Receptor Modulators Product Portfolio
  30. 4.5.5 Sanofi Recent Developments
  31. 4.6 Novartis
  32. 4.6.1 Novartis Company Information
  33. 4.6.2 Novartis Business Overview
  34. 4.6.3 Novartis GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Novartis GABA Receptor Modulators Product Portfolio
  36. 4.6.5 Novartis Recent Developments
  37. 4.7 Mylan
  38. 4.7.1 Mylan Company Information
  39. 4.7.2 Mylan Business Overview
  40. 4.7.3 Mylan GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Mylan GABA Receptor Modulators Product Portfolio
  42. 4.7.5 Mylan Recent Developments
  43. 4.8 Roche
  44. 4.8.1 Roche Company Information
  45. 4.8.2 Roche Business Overview
  46. 4.8.3 Roche GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Roche GABA Receptor Modulators Product Portfolio
  48. 4.8.5 Roche Recent Developments
  49. 4.9 Pfizer
  50. 4.9.1 Pfizer Company Information
  51. 4.9.2 Pfizer Business Overview
  52. 4.9.3 Pfizer GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Pfizer GABA Receptor Modulators Product Portfolio
  54. 4.9.5 Pfizer Recent Developments
  55. 4.10 Huazhong Pharmaceutical
  56. 4.10.1 Huazhong Pharmaceutical Company Information
  57. 4.10.2 Huazhong Pharmaceutical Business Overview
  58. 4.10.3 Huazhong Pharmaceutical GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Huazhong Pharmaceutical GABA Receptor Modulators Product Portfolio
  60. 4.10.5 Huazhong Pharmaceutical Recent Developments
  61. 4.11 Sichuan HaiscoPharmaceuical
  62. 4.11.1 Sichuan HaiscoPharmaceuical Company Information
  63. 4.11.2 Sichuan HaiscoPharmaceuical Business Overview
  64. 4.11.3 Sichuan HaiscoPharmaceuical GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Sichuan HaiscoPharmaceuical GABA Receptor Modulators Product Portfolio
  66. 4.11.5 Sichuan HaiscoPharmaceuical Recent Developments
  67. 4.12 GSK
  68. 4.12.1 GSK Company Information
  69. 4.12.2 GSK Business Overview
  70. 4.12.3 GSK GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 GSK GABA Receptor Modulators Product Portfolio
  72. 4.12.5 GSK Recent Developments
  73. 4.13 Fresenius Kabi
  74. 4.13.1 Fresenius Kabi Company Information
  75. 4.13.2 Fresenius Kabi Business Overview
  76. 4.13.3 Fresenius Kabi GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Fresenius Kabi GABA Receptor Modulators Product Portfolio
  78. 4.13.5 Fresenius Kabi Recent Developments
  79. 4.14 Changzhou Siyao Pharmaceutical
  80. 4.14.1 Changzhou Siyao Pharmaceutical Company Information
  81. 4.14.2 Changzhou Siyao Pharmaceutical Business Overview
  82. 4.14.3 Changzhou Siyao Pharmaceutical GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Changzhou Siyao Pharmaceutical GABA Receptor Modulators Product Portfolio
  84. 4.14.5 Changzhou Siyao Pharmaceutical Recent Developments
  85. 4.15 AstraZeneca
  86. 4.15.1 AstraZeneca Company Information
  87. 4.15.2 AstraZeneca Business Overview
  88. 4.15.3 AstraZeneca GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 AstraZeneca GABA Receptor Modulators Product Portfolio
  90. 4.15.5 AstraZeneca Recent Developments
  91. 4.16 WG Critical Care
  92. 4.16.1 WG Critical Care Company Information
  93. 4.16.2 WG Critical Care Business Overview
  94. 4.16.3 WG Critical Care GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 WG Critical Care GABA Receptor Modulators Product Portfolio
  96. 4.16.5 WG Critical Care Recent Developments
  97. 4.17 Viatris
  98. 4.17.1 Viatris Company Information
  99. 4.17.2 Viatris Business Overview
  100. 4.17.3 Viatris GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Viatris GABA Receptor Modulators Product Portfolio
  102. 4.17.5 Viatris Recent Developments
  103. 4.18 Torrent Pharma
  104. 4.18.1 Torrent Pharma Company Information
  105. 4.18.2 Torrent Pharma Business Overview
  106. 4.18.3 Torrent Pharma GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Torrent Pharma GABA Receptor Modulators Product Portfolio
  108. 4.18.5 Torrent Pharma Recent Developments
  109. 4.19 Sandoz
  110. 4.19.1 Sandoz Company Information
  111. 4.19.2 Sandoz Business Overview
  112. 4.19.3 Sandoz GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Sandoz GABA Receptor Modulators Product Portfolio
  114. 4.19.5 Sandoz Recent Developments
  115. 4.20 SAGE Therapeutics
  116. 4.20.1 SAGE Therapeutics Company Information
  117. 4.20.2 SAGE Therapeutics Business Overview
  118. 4.20.3 SAGE Therapeutics GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 SAGE Therapeutics GABA Receptor Modulators Product Portfolio
  120. 4.20.5 SAGE Therapeutics Recent Developments
  121. 4.21 Neurelis
  122. 4.21.1 Neurelis Company Information
  123. 4.21.2 Neurelis Business Overview
  124. 4.21.3 Neurelis GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Neurelis GABA Receptor Modulators Product Portfolio
  126. 4.21.5 Neurelis Recent Developments
  127. 4.22 Jazz Pharmaceuicals
  128. 4.22.1 Jazz Pharmaceuicals Company Information
  129. 4.22.2 Jazz Pharmaceuicals Business Overview
  130. 4.22.3 Jazz Pharmaceuicals GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Jazz Pharmaceuicals GABA Receptor Modulators Product Portfolio
  132. 4.22.5 Jazz Pharmaceuicals Recent Developments
  133. 4.23 Hikma
  134. 4.23.1 Hikma Company Information
  135. 4.23.2 Hikma Business Overview
  136. 4.23.3 Hikma GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Hikma GABA Receptor Modulators Product Portfolio
  138. 4.23.5 Hikma Recent Developments
  139. 4.24 CHEPLAPHARM
  140. 4.24.1 CHEPLAPHARM Company Information
  141. 4.24.2 CHEPLAPHARM Business Overview
  142. 4.24.3 CHEPLAPHARM GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 CHEPLAPHARM GABA Receptor Modulators Product Portfolio
  144. 4.24.5 CHEPLAPHARM Recent Developments
  145. 4.25 Apotex
  146. 4.25.1 Apotex Company Information
  147. 4.25.2 Apotex Business Overview
  148. 4.25.3 Apotex GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  149. 4.25.4 Apotex GABA Receptor Modulators Product Portfolio
  150. 4.25.5 Apotex Recent Developments
  151. 4.26 Akorn
  152. 4.26.1 Akorn Company Information
  153. 4.26.2 Akorn Business Overview
  154. 4.26.3 Akorn GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  155. 4.26.4 Akorn GABA Receptor Modulators Product Portfolio
  156. 4.26.5 Akorn Recent Developments
5 Global GABA Receptor Modulators Market Scenario by Region
  1. 5.1 Global GABA Receptor Modulators Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global GABA Receptor Modulators Sales by Region: 2021-2032
  3. 5.2.1 Global GABA Receptor Modulators Sales by Region: 2021-2026
  4. 5.2.2 Global GABA Receptor Modulators Sales by Region: 2027-2032
  5. 5.3 Global GABA Receptor Modulators Revenue by Region: 2021-2032
  6. 5.3.1 Global GABA Receptor Modulators Revenue by Region: 2021-2026
  7. 5.3.2 Global GABA Receptor Modulators Revenue by Region: 2027-2032
  8. 5.4 North America GABA Receptor Modulators Market Facts & Figures by Country
  9. 5.4.1 North America GABA Receptor Modulators Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America GABA Receptor Modulators Sales by Country (2021-2032)
  11. 5.4.3 North America GABA Receptor Modulators Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe GABA Receptor Modulators Market Facts & Figures by Country
  15. 5.5.1 Europe GABA Receptor Modulators Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe GABA Receptor Modulators Sales by Country (2021-2032)
  17. 5.5.3 Europe GABA Receptor Modulators Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific GABA Receptor Modulators Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific GABA Receptor Modulators Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific GABA Receptor Modulators Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific GABA Receptor Modulators Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America GABA Receptor Modulators Market Facts & Figures by Country
  35. 5.7.1 South America GABA Receptor Modulators Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America GABA Receptor Modulators Sales by Country (2021-2032)
  37. 5.7.3 South America GABA Receptor Modulators Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa GABA Receptor Modulators Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa GABA Receptor Modulators Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa GABA Receptor Modulators Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa GABA Receptor Modulators Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global GABA Receptor Modulators Sales by Type (2021-2032)
  2. 6.1.1 Global GABA Receptor Modulators Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global GABA Receptor Modulators Sales Market Share by Type (2021-2032)
  4. 6.2 Global GABA Receptor Modulators Revenue by Type (2021-2032)
  5. 6.2.1 Global GABA Receptor Modulators Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global GABA Receptor Modulators Revenue Market Share by Type (2021-2032)
  7. 6.3 Global GABA Receptor Modulators Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global GABA Receptor Modulators Sales by Application (2021-2032)
  2. 7.1.1 Global GABA Receptor Modulators Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global GABA Receptor Modulators Sales Market Share by Application (2021-2032)
  4. 7.2 Global GABA Receptor Modulators Revenue by Application (2021-2032)
  5. 7.2.1 Global GABA Receptor Modulators Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global GABA Receptor Modulators Revenue Market Share by Application (2021-2032)
  7. 7.3 Global GABA Receptor Modulators Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 GABA Receptor Modulators Value Chain Analysis
  2. 8.1.1 GABA Receptor Modulators Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 GABA Receptor Modulators Production Mode & Process
  5. 8.2 GABA Receptor Modulators Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 GABA Receptor Modulators Distributors
  8. 8.2.3 GABA Receptor Modulators Customers
9 Global GABA Receptor Modulators Analyzing Market Dynamics
  1. 9.1 GABA Receptor Modulators Industry Trends
  2. 9.2 GABA Receptor Modulators Industry Drivers
  3. 9.3 GABA Receptor Modulators Industry Opportunities and Challenges
  4. 9.4 GABA Receptor Modulators Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst